[Say no to the extremes in the debate on lipid reduction].
Paul.Hjemdahl@ki.se
Paul
P
Hjemdahl
Anette
A
Allhammar
Johan
J
Eklund
Tomas
T
Forslund
Johan
J
Hulting
Thomas
T
Kahan
Arne
A
Martinsson
Rickard
R
Malmström
Franz
F
Rücker
Karin
K
Schenck-Gustafsson
Jonas
J
Schwieler
Mattias
M
Törnerud
Björn
B
Wettermark
D000924:Anticholesteremic Agents / Q000008:administration & dosage*; D002318:Cardiovascular Diseases / Q000517:prevention & control; D008078:Cholesterol, LDL / Q000097:blood*; D019317:Evidence-Based Medicine; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage*; D017410:Practice Guidelines as Topic; D019821:Simvastatin / Q000008:administration & dosage*
D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D019821:Simvastatin